| 2024/04/25 21:59:56 | |
|---|---|
| Price | |
| 4.513 EUR | |
| Difference | -3.07% (-0.14) |
General attributes
| ISIN | CA05156V1022 |
| Symbol | AUPH |
| Exchange | Stuttgart |
| Currency | EUR |
| Sector | Chemical / Pharmaceutical / Health |
| Security type | Stock |
| Market cap (m) | 657 EUR |
| Benchmark | S&P/TSX 60 INDEX |
Market data
| Bid (Bid size) | - (0) |
| Ask (Ask size) | - (0) |
| Open | 4.64 EUR |
| High | 4.64 EUR |
| Low | 4.454 EUR |
| Close (prev. day) | 4.656 EUR |
| VWAP | - |
| Volume (pcs) | 0 |
| Trading volume | 0.00 |
| Number of trades | 6 |
| Last size | 0 |
Futures and Options
| Related Futures | - |
| Related Options | - |
Scale: ABS REL
Instrument
Add Benchmark:
Information about previous performance does not guarantee future performance.Source: FactSet
Recent research
| Date | Headline | Download | |
| 2024/04/03 |
|
Global Equity Ratings |
|
| 2024/03/13 |
|
Global Equity Ratings |
|
| 2024/02/22 |
|
Global Equity Ratings |
|
| 2024/02/14 |
|
Global Equity Ratings |
|
| 2024/01/23 |
|
Global Equity Ratings |
|
| 2024/04/25 21:59:56 | |
|---|---|
| Price | |
| 4.513 EUR | |
| Difference | -3.07% (-0.14) |
General attributes
| ISIN | CA05156V1022 |
| Symbol | AUPH |
| Exchange | Stuttgart |
| Currency | EUR |
| Sector | Chemical / Pharmaceutical / Health |
| Security type | Stock |
| Market cap (m) | 657 EUR |
| Benchmark | S&P/TSX 60 INDEX |
Market data
| Bid (Bid size) | - (0) |
| Ask (Ask size) | - (0) |
| Open | 4.64 EUR |
| High | 4.64 EUR |
| Low | 4.454 EUR |
| Close (prev. day) | 4.656 EUR |
| VWAP | - |
| Volume (pcs) | 0 |
| Trading volume | 0.00 |
| Number of trades | 6 |
| Last size | 0 |
Performance and Risk
| 6m | 1Y | 3Y | |
| Perf (%) | -35.34% | -56.18% | -57.08% |
| Perf (abs.) | -2.47 | -5.79 | -6.00 |
| Beta | 1.52 | 1.21 | 1.60 |
| Volatility | 63.07 | 61.59 | 82.84 |
Scale: ABS REL
Instrument
Add Benchmark:
Information about previous performance does not guarantee future performance.Source: FactSet
Price data
| Ø price 5 days | Ø volume 5 days (pcs.) | 4.645 EUR (0) |
| Ø price 30 days | Ø volume 30 days (pcs.) | 4.658 EUR (33) |
| Ø price 100 days | Ø volume 100 days (pcs.) | 6.306 EUR (106) |
| Ø price 250 days | Ø volume 250 days (pcs.) | 7.667 EUR (104) |
| YTD High | date | 8.430 EUR (2024/01/09) |
| YTD Low | date | 4.444 EUR (2024/04/18) |
| 52 Weeks High | date | 11.300 EUR (2023/07/31) |
| 52 Weeks Low | date | 4.444 EUR (2024/04/18) |
All listings for AURINIA PHARMACEUTICALS INC.
| Exchange | Date | Time | Price | Trading volume (mio.) | Number of trades |
| Tradegate | 2024/04/25 | 22:26 | 4.535 EUR | 0.00 | 2 |
| Stuttgart | 2024/04/25 | 21:59 | 4.513 EUR | 0.00 | 6 |
| Nasdaq | 2024/04/25 | 22:00 | 4.87 USD | 7.46 | 7,887 |
| Munich | 2024/04/25 | 08:11 | 4.715 EUR | 0.00 | 1 |
| London Stock Exchange | 2021/02/05 | 16:52 | 19.6090 CAD | 0.00 | 1 |
| Frankfurt | 2024/04/25 | 21:50 | 4.43 EUR | 0.00 | 3 |
| Duesseldorf | 2024/04/25 | 19:31 | 4.476 EUR | 0.00 | 7 |
| Berlin | 2024/04/25 | 08:13 | 4.641 EUR | 0.00 | 2 |
Company Profile
| - |
Board of directors
| Daniel Billen | Chairman of Supervisory Board |
| Brinda Balakrishnan | Member of Supervisory Board |
| David Jaynee | Member of Supervisory Board |
| Karen Smith | Member of Supervisory Board |
| Robert Foster | Member of Supervisory Board |
| Jeffrey Bailey | Member of Supervisory Board |
| Jill Leversage | Member of Supervisory Board |
| R. MacKay-Dunn | Member of Supervisory Board |